[1]
Ciotti, S. et al. 2021. Treatment with Delta-9-tetrahydrocannabinol/cannabidiol in Multiple Sclerosis: Influence on the Autonomy Profile according to the International Classification of Functioning, Disability and Health. European Journal of Case Reports in Internal Medicine. 8, 9 (Oct. 2021). DOI:https://doi.org/10.12890/2021_002298.